January 2023 – COA Patient Advocacy Network News Bulletin
Advocacy Chats – Educational Conversations on Cancer Advocacy and Policy Issues
COA’s Crystal Ball for 2023
With a new year and a new Congress, what developments in cancer policy can advocates expect? Join COA Director of Patient Advocacy & Education, Rose Gerber, MS; COA Managing Director of Policy, Advocacy, and Communications, Nick Ferreyros; and COA Executive Director, Ted Okon, MBA, to learn what 2023 could mean for cancer care on Wednesday, January 11 at 12:00 p.m. ET. Register today.
ICYMI: What’s Legal About Cancer? Insurance, Employment, and Finances
When a patient receives a cancer diagnosis, questions often come up about insurance coverage, the future of employment, and how to pay for treatment. COA’s Rose Gerber spoke with Triage Cancer Chief Operating Officer Monica Fawzy Bryant, Esq, to discuss the legal and financial issues facing cancer patients. Stream it on @OncologyCOA’s YouTube channel today.
Advocacy Spotlight: Amplifying the Voices of CPAN Advocates
Thousands of CPAN advocates have worked to protect community oncology for more than a decade, and each one has a powerful personal story. Some advocates join CPAN following treatment in a community oncology setting, some join as community oncology professionals, and some join to support loved ones. No matter the reason, each advocate knows firsthand the value of locally delivered cancer care, and the power of CPAN’s collective voice.
CPAN will spotlight and celebrate the efforts and stories of advocates and chapter leaders throughout 2023. CPAN will feature what led each member to advocate for community oncology, what they value about locally delivered cancer care, and the importance of organizations like CPAN to them.
- To learn more about why CPAN advocates are committed to protecting locally delivered cancer care, visit CPAN’s Patient & Advocate Stories page.
Cancer News You Can Use
Many U.S. Women Must Travel Far To Get Mammograms – HealthDay 12/19
Researchers found that 8.2 million women had limited access to mammography screening in 2022—defined as living more than a 20-minute drive to the nearest facility. That was up from 7.5 million in 2006. Not surprisingly, women in rural areas were most affected: In rural regions of 28 states, more than half of women had limited mammography access due to where they lived.
Only 14% Of Diagnosed Cancers In The U.S. Are Detected By Screening, Report Says – CNN 12/14
A small proportion—14.1%—of all diagnosed cancers in the United States are detected by screening with a recommended screening test, according to a new report. The remaining diagnosed cancers tend to be found when someone has symptoms or seeks imaging or medical care for other reasons, suggests the report, authored by researchers at the nonprofit organization NORC at the University of Chicago.
After Breast Cancer, Women May Safely Stop Long-Term Therapies To Have A Baby – NBC 12/08
The first study to address head-on a major issue for young breast cancer survivors—the opportunity to have a baby—finds it’s safe, at least temporarily, to pause treatment in order to get pregnant. Until now, there had been no solid evidence that women who stopped taking hormone-reducing drugs so they could have a baby could do so without further increasing their risk of recurrence.
Community Oncology 101 – Spotlight on Cancer Care: Commitment to Patients
How can community oncologists provide high-quality cancer care? At New England Cancer Specialists, the first step is ensuring that the patient is priority number one. Learn more in this Spotlight on Cancer Care.
Resources for Chapters
Make spreading the word about community oncology your New Year’s resolution! Visit CPAN’s Advocacy Resources library to find educational video content to share on social media and request customized advocacy materials to fit your practice’s needs.
Recent News & Updates
Nicolas Ferreyros: There Is Growing Recognition the 340B Program Is “Out of Control” Shares His Thoughts on the 340B Drug Pricing Program
With new investigations into the 340B drug pricing program, there is growing awareness of the issues and lack of transparency around where those drug discounts go, explained Nicolas Ferreyros, BA, managing director of policy, advocacy, and communications at the Community Oncology Alliance (COA).
The traditional treatment for early-stage non-small cell lung cancer is a lobectomy, where a surgeon eradicates cancerous tissue by removing an entire lung lobe.
If you think you're too young to get colorectal cancer, consider this: About 20,000 people in the U.S. under the age of 50 will be diagnosed this year.
On January 1, a provision of the Inflation Reduction Act (IRA) went into effect requiring drug companies to pay rebates to Medicare when prescription drug prices increase faster than the rate of inflation for certain drugs given to people enrolled in the program.